QQQ vs URGN Stock Comparison
URGN currently leads QQQ in this stock comparison, with AIQ scores of 53 vs 46. The clearest difference is value, while QQQ has the stronger quality profile.
What is the main difference between QQQ and URGN?
URGN leads the current stock comparison as UroGen Pharma Ltd., with the clearest separation coming from value and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Invesco QQQ Trust, Series 1 vs UroGen Pharma Ltd.
URGN leads
URGN leads by 7 AIQ points, primarily on Value and Risk Resilience, and the lead has widened from 0 points over 30 sessions.
Competitive: 3 of 4 evidence groups support URGN, its lead is widening, and its current signal state is conflicted.
Invesco QQQ Trust, Series 1
UroGen Pharma Ltd.
The Algovestiq AIQ Score currently favors URGN over QQQ, 53 versus 46 as of Nov 15, 2026. URGN's advantage is driven primarily by stronger value and risk resilience, while QQQ holds the stronger quality profile. URGN also shows the weaker technical structure relative to its 50-day moving average. 3 of 4 covered evidence groups favor URGN today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. URGN lead: Strengthening — the AIQ differential moved from 0 to 7 points over 30 sessions.
Compare Invesco QQQ Trust, Series 1 and UroGen Pharma Ltd. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare QQQ and URGN against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value13 vs 64URGN +51
- Quality93 vs 68QQQ +25
- Risk Resilience31 vs 40URGN +9
- Momentum33 vs 40URGN +7
3 of 4 evidence groups favor URGN. URGN’s edge is concentrated in value and risk resilience; QQQ keeps a meaningful quality edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Value +1
New signals
- Price Lost 200-Day MA — bearish, trend, long horizon
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-14.8%)
Largest factor move: Value +2, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 5 active signals are unchanged.
URGN's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — QQQ and URGN both carry a full feed there.
The central trade-off
URGN (UroGen Pharma Ltd.): the stronger current systematic profile, led by value and risk resilience.
QQQ (Invesco QQQ Trust, Series 1): the counter-case, on quality, technicals.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
URGNURGN on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
EvenGrowth figures are not covered for both names.
Value
URGNURGN on the peer-relative Value factor, by 51 points.
Momentum
URGNURGN on the Momentum factor, by 7 points.
Lower downside
URGNURGN on Risk Resilience, by 9 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | QQQ | URGN | Note |
|---|---|---|---|
| Implied upside to target | — | +121.5% | Level |
| Target dispersion | — | +6.9% | Lower is tighter analyst agreement |
| Consensus | — | Buy | Context, not a primary driver |
| Analysts covering | — | 8 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 4 covered evidence groups favor URGN. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | URGN | 46 vs 53 |
| Fundamentals | Not covered | Not covered |
| Valuation | URGN | Value 13 vs 64 |
| Technicals | QQQ | Price vs 50-day -5.3% vs -29.2%; vs 200-day -0.3% vs -17.4% |
| Risk Resilience | URGN | Risk Resilience 31 vs 40 |
| Analyst expectations | Not covered | Not covered |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of QQQ and URGN and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is moderate at 7 points.
- The leader's advantage has been widening. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on URGN.
How the comparison changed
120 daily snapshots · May 27 – Nov 13URGN lead: Strengthening — the AIQ differential moved from 0 to 7 points over 30 sessions.
- Today
- URGN +7
- 46 vs 53
- 7 sessions ago
- URGN +7
- 50 vs 57
- 30 sessions ago
- Level
- 63 vs 63
- 90 sessions ago
- URGN +14
- 56 vs 70
The lead changed hands 2 times in this window, most recently on Nov 5 when URGN moved ahead of QQQ.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 1 bearish, conflicted
Only QQQ
- Price Lost 200-Day MA — bearish, trend, long horizon
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-14.8%)
2 bullish / 1 bearish / 2 neutral, conflicted
Only URGN
- ADX Trend Strengthening — neutral, trend, medium horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (7.71%)
- Keltner Channel Breakdown — bearish, volatility, short horizon
- RSI Oversold — bullish, momentum, short horizon
Both carry 1 more signal that do not separate them: Golden Cross Active.
URGN leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved down over the latest session (price -1.2%, AIQ -1 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.8%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1QQQ closes the Value gap — currently 51 points behind, the largest single contributor to URGN's edge.
- 2QQQ's Price Lost 200-Day MA resolves — a bearish trend rule currently active against it.
- 3URGN's conflicting signal state resolves bearish — it currently carries 2 bullish and 1 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | QQQ | URGN |
|---|---|---|
| Revenue growth (YoY) | — | 22.8% |
| EPS growth (YoY) | — | 89.3% |
| Gross margin | — | 91.4% |
| Operating margin | — | -12.4% |
| Return on equity (TTM) | — | 1.2% |
| Debt to equity | — | -1.57 |
Performance
QQQ leads 4 of 6 windows| Metric | QQQ | URGN |
|---|---|---|
| 1 week (5 sessions) | 3.6% | 5.8% |
| 1 month (20 sessions) | -4.2% | -24.2% |
| 3 months (63 sessions) | -6.8% | -46.7% |
| 6 months (126 sessions) | -4.1% | -9% |
| Year to date | 10.7% | 11.8% |
| 1 year (252 sessions) | 9.5% | 4.1% |
Technicals
QQQ has the stronger structure| Metric | QQQ | URGN |
|---|---|---|
| RSI (14) | 42.8 | 28.7 |
| ADX (14) | 30.3 | 45.1 |
| Price vs 50-day | -5.3% | -29.2% |
| Price vs 200-day | -0.3% | -17.4% |
| Volatility (1M, annualized) | 35.4% | 79.4% |
Risk
URGN is the more resilient| Metric | QQQ | URGN |
|---|---|---|
| Beta | 1.46 | 1.33 |
| Sharpe ratio | 0.44 | 0.39 |
| Sortino ratio | 0.62 | 0.56 |
| Max drawdown | -14.8% | -50.8% |
| Current drawdown | -10.5% | -47.9% |
| Annualized volatility | 21.5% | 61.9% |
| Value at risk (95%) | -2% | -5.5% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, QQQ or URGN?
On the Algovestiq AIQ Score, URGN is the stronger of the two as of Nov 15, 2026, scoring 53 against QQQ's 46. The edge comes from value and risk resilience. QQQ is not without a case — it holds the better quality profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is QQQ or URGN the better buy right now?
URGN carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 3 of 4 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor URGN over QQQ?
The composite weights Quality, Value, Momentum and Risk Resilience. URGN leads Value by 51 points; QQQ leads Quality by 25 points; URGN leads Risk Resilience by 9 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, QQQ or URGN?
Analyst price targets imply not covered upside for QQQ and +121.5% for URGN. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, QQQ or URGN?
URGN is the better-valued of the two on the peer-relative Value factor. URGN on the peer-relative Value factor, by 51 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, QQQ or URGN?
Growth figures are not covered for both names. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, QQQ or URGN?
URGN on the Momentum factor, by 7 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, QQQ or URGN?
URGN is the more resilient of the two, so the other name carries the higher downside risk. URGN on Risk Resilience, by 9 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is QQQ more profitable than URGN?
Margin data is not comparable for both names in the current snapshot.
Is URGN's lead over QQQ getting stronger or weaker?
URGN lead: Strengthening — the AIQ differential moved from 0 to 7 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 2 times in that window, most recently on 2026-11-05, when URGN moved ahead of QQQ.
What would change the QQQ vs URGN verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: QQQ closes the Value gap — currently 51 points behind, the largest single contributor to URGN's edge; QQQ's Price Lost 200-Day MA resolves — a bearish trend rule currently active against it; URGN's conflicting signal state resolves bearish — it currently carries 2 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about QQQ and URGN?
QQQ: 2 bullish / 1 bearish, conflicted. URGN: 2 bullish / 1 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on QQQ is Golden Cross Active (bullish, long horizon). On URGN it is Golden Cross Active (bullish, long horizon).
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.